Skip to main content

ACCORD BIOPHARMA INC

1 ongoing recall currently shown

Based on the official records currently available to Public Health Trace, 1 recall naming ACCORD BIOPHARMA INC is currently shown as ongoing.

Public Health Trace has 1 recall naming ACCORD BIOPHARMA INC as the recalling firm, republished from official FDA and USDA sources.

Recall records - 1 total

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20261
Download CSV

FDA Recall Ongoing2026 recordClass II

IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Indiana, LLC, 1300 S. Patterson Drive, Bloomington, IN 47403, USA, NDC 69448-019-26.

by ACCORD BIOPHARMA INC

Reason
Lack of assurance of Sterility:
Published
July 8, 2026
Distribution
Nationwide

View recall →

Showing 1–1 of 1 results

Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

This page lists recalls that name ACCORD BIOPHARMA INC as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.